P Farha
Overview
Explore the profile of P Farha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laberge F, Fritsche H, Umsawasdi T, CARR D, Welch S, Murphy W, et al.
Cancer
. 1987 Jun;
59(12):2047-52.
PMID: 3032400
Carcinoembryonic antigen (CEA) was measured in 147 patients at diagnosis of small cell lung cancer; 17% of patients with limited disease and 51% with extensive disease had an abnormal CEA...
2.
Spitzer G, Valdivieso M, Farha P, Murphy W, Dhingra H, Chiuten D, et al.
Cancer Treat Rep
. 1986 Apr;
70(4):449-53.
PMID: 3698037
Thirty-six patients with lung cancer, 24 with prior chemotherapy and 12 without prior chemotherapy, received iv melphalan at doses ranging from 20 to 40 mg/m2 of body surface area. Patients...
3.
Spitzer G, Farha P, Valdivieso M, Dicke K, Zander A, Vellekoop L, et al.
J Clin Oncol
. 1986 Jan;
4(1):4-13.
PMID: 3510281
The efficacy and toxicity of high-dose chemotherapy with autologous bone marrow transplantation (ABMT) was studied in 32 patients with untreated limited small-cell bronchogenic carcinoma (SCBC). Ten patients received three courses...
4.
Umsawasdi T, Valdivieso M, BARKLEY Jr H, Booser D, Chiuten D, Murphy W, et al.
Int J Radiat Oncol Biol Phys
. 1985 Mar;
11(3):511-9.
PMID: 3838297
Esophageal complications from combined chemoradiotherapy (CCRT) were analyzed in 55 patients with limited non-small cell lung cancer. CCRT consisted of chemotherapy (cyclophosphamide, doxorubicin (Adriamycin), and cisplatin: CAP) and chest irradiation...
5.
Kalter S, Dhingra H, Farha P
South Med J
. 1985 Feb;
78(2):197-8.
PMID: 2983440
We have described a patient with small cell cancer of the lung manifested as the Eaton-Lambert syndrome. Primary therapy proved effective in reversing the syndrome, whereas anticholinesterase agents did not....
6.
Dhingra H, Valdivieso M, CARR D, Chiuten D, Farha P, Murphy W, et al.
J Clin Oncol
. 1985 Feb;
3(2):176-83.
PMID: 2981982
One hundred sixty-seven evaluable patients with non-small-cell lung cancer were randomized to receive high-dose cisplatin and vindesine (PVD), or cisplatin and VP-16-213 (etoposide epipodophyllotoxin) (PVP), or cisplatin with VP-16-213 and...
7.
Valdivieso M, Farha P, McMurtrey M, Spitzer G, Frazier Jr O, BARKLEY Jr H, et al.
Tex Med
. 1984 Aug;
80(8):38-42.
PMID: 6484859
No abstract available.
8.
Dhingra H, Valdivieso M, Booser D, Umsawasdi T, CARR D, Chiuten D, et al.
Cancer Treat Rep
. 1984 Apr;
68(4):671-3.
PMID: 6538811
Forty-one patients with unselected advanced non-small cell lung cancer were treated with a combination of etoposide and cisplatin. A response rate of 19%, a 78-week median survival of responders, and...
9.
Umsawasdi T, Valdivieso M, Chen T, BARKLEY Jr H, Booser D, Chiuten D, et al.
J Neurooncol
. 1984 Jan;
2(3):253-9.
PMID: 6389779
We have studied the clinical impact of elective brain irradiation (EBI) in patients with locally advanced, non-small cell lung cancer (LA-NSC). All patients received combination chemotherapy (cyclophosphamide + doxorubicin (Adriamycin)...
10.
Farha P, Spitzer G, Valdivieso M, Dicke K, Zander A, Dhingra H, et al.
Cancer
. 1983 Oct;
52(8):1351-5.
PMID: 6311392
Fourteen patients with untreated small cell bronchogenic carcinoma were treated initially with 2 chemotherapy courses of cyclophosphamide (1.5 g/m2 days 1-3), 4-dimethyl epipodophylloxtin (200 mg/m2 days 1-3), vincristine (1.5 mg/m2...